Brain scans used to match smokers with best Quit-Aid
NCT ID NCT02162849
Summary
This study aims to find out if the quit-smoking drug varenicline (Chantix) or nicotine patches work better when paired with counseling, depending on a person's personality and how their brain responds to rewards. Researchers enrolled 204 adult smokers and randomly assigned them to receive one of the two medications (plus a placebo for the other) along with behavioral counseling. They measured brain activity with EEG tests to see if it predicts which treatment works best for each individual.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TOBACCO USE CESSATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Texas MD Anderson Cancer Center
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.